Myovant Sciences Ltd. Marketable Securities (Current)
Myovant Sciences Ltd. had Marketable Securities (Current) of $23.85 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2023-01-26
- 2022-12-31: Marketable Securities, Current $23.85M.
- 2022-09-30: Marketable Securities, Current $29.33M.
- 2022-06-30: Marketable Securities, Current $31.22M.
- 2022-03-31: Marketable Securities, Current $27.48M.
| Period end | Marketable Securities, Current |
|---|---|
| 2022-12-31 | $23.85M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $29.33M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $31.22M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $27.48M 10-Q · filed 2023-01-26 |
| 2021-12-31 | $70.02M 10-Q · filed 2022-01-26 |
| 2021-09-30 | $97.85M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $84.83M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $10.44M 10-K · filed 2022-05-11 |
| 2020-12-31 | $32.32M 10-Q · filed 2021-02-11 |
| 2020-09-30 | $17.09M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $14.97M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $3.00M 10-K · filed 2021-05-11 |
| 2019-12-31 | $15.81M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $27.22M 10-Q · filed 2019-11-12 |
| 2019-03-31 | $0.00 10-K · filed 2020-05-18 |